Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2001
04/18/2001EP1092770A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
04/18/2001EP1092769A2 Polypeptid-tag's for the detection and purification of polypeptides
04/18/2001EP1092728A2 Biologically digestable complex of orthosilicic acid in a solid, stable and concentrated form and proces for its preparation
04/18/2001EP1092727A2 G-protein receptor
04/18/2001EP1092726A2 Radioactively-labeled somatostatin derived peptides for imaging and therapeutics uses
04/18/2001EP1092725A1 Saccharide transporter
04/18/2001EP1092724A2 Angiotensin converting enzyme inhibitor
04/18/2001EP1092154A2 Detection and modulation of cellular immunity to immune privileged antigens
04/18/2001EP1092153A2 Method and composition to detect c-type retroviral infection
04/18/2001EP1092040A2 METHODS OF INHIBITING $i(HELICOBACTER PYLORI)
04/18/2001EP1092038A1 OCT1p, A PROTEIN HAVING HOMOLOGY TO THE ORGANIC AND SUGAR TRANSPORTER FAMILY OF PROTEINS, AND USES THEREOF
04/18/2001EP1092037A1 Cell culture process for producing glycoproteins
04/18/2001EP1092036A1 Method for catalysing complex reactions of large molecules using enzymes which are bonded to a polymer support
04/18/2001EP1092034A2 Inducible promoters
04/18/2001EP1092031A2 Marburg virus vaccines
04/18/2001EP1092030A2 Flt3-l mutants and methods of use
04/18/2001EP1092029A1 A novel human thrombopoietin mutein
04/18/2001EP1092027A1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same
04/18/2001EP1092026A2 Neurotransmission associated proteins
04/18/2001EP1092025A1 Human emr1-like g protein coupled receptor
04/18/2001EP1092024A2 14273 receptor, a g-protein coupled receptor
04/18/2001EP1092023A2 Molecules associated with apoptosis
04/18/2001EP1092022A2 Immune system molecules
04/18/2001EP1092021A1 Npy-y7 receptor gene
04/18/2001EP1092020A1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid
04/18/2001EP1092019A1 Human homologue of unc-53 protein of c. elegans
04/18/2001EP1092018A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT
04/18/2001EP1092017A1 Novel gaba-b receptor
04/18/2001EP1091980A1 Compositions and methods for identifying apoptosis signaling pathway inhibitors and activators
04/18/2001EP1091979A1 Seeding crystals for the preparation of peptides or proteins
04/18/2001EP1091978A2 Synthetic spiroketal pyranes as potent anti-cancer agents
04/18/2001EP1091977A2 A method of identifying hormone receptor ligands
04/18/2001EP1091976A2 Peptides from varicella-zoster and other viruses for hiv-2 diagnosis and therapy
04/18/2001EP1091948A2 Tubulin binding compounds (cobra)
04/18/2001EP1091759A2 Composition for the induction of apoptosis in target cells
04/18/2001EP1091756A2 Haemophilus parasuis vaccine and diagnostic
04/18/2001EP0851872B1 Urogenital carcinoma tlp complex peptides and antibodies thereof
04/18/2001EP0815438A4 Characterization of individual polymer molecules based on monomer-interface interactions
04/18/2001EP0802795A4 Neurological drug screens
04/18/2001EP0766566B1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
04/18/2001EP0725790B1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
04/18/2001EP0437579B1 Enhancement of naphthalene dioxygenase activity during microbial indigo production
04/18/2001CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy
04/18/2001CN1292031A Methods for producing polypeptide in bacillus cell
04/18/2001CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use
04/18/2001CN1291995A Enhancing circulating half-life of antibody-based fusion proteins
04/18/2001CN1291992A Isolated, polypeptides which bind to HLA-A29 molecules, nucleic acid, molecules encoding there, and uses thereof
04/18/2001CN1291991A Novel peptide having biological activity
04/18/2001CN1291651A New nucleotide sequence of encode thrE gene and method of producing L-threonine using corynebacterium enzyme
04/18/2001CN1291650A Human hepatome derivative growth factor coding sequence, polypeptide coded with it and its preparing process
04/18/2001CN1291617A RIM2 protein
04/18/2001CN1291616A Process for separating and purifying high-purity high-activity phycocyanin
04/18/2001CN1064710C Therapeutic uses of keratinocyte growth factor
04/18/2001CN1064690C Shark-cartrilage blood-vessel generation inhibitory factor and separating and purifying method therefor
04/18/2001CN1064552C Method for inactivating viruses devoid of lipid envelopes
04/18/2001CA2321437A1 Dna encoding structural protein-1 of infectious salmon anaemia virus and uses thereof
04/17/2001US6218596 Enhancement of musculature in non-human mammals expressing c-ski
04/17/2001US6218595 Genetically engineered cells; for use as test models in the treatment of parkinson's disease or dyskinesis
04/17/2001US6218529 Nucleotide sequences; for the detection and treatment of tumors
04/17/2001US6218528 MurB
04/17/2001US6218527 Nucleotide sequences coding transcription factor; for the generation of transgenic plants that are tolerant to environmental stresses
04/17/2001US6218526 Polynucleotide encoding human netrin-1
04/17/2001US6218525 Nucleic acid encoding CD28
04/17/2001US6218523 Nucleotide sequences which can be used to detect adjustment in the genome; for the detection of modulators of preferential gene expression; for diagnosis and treatment of tumors
04/17/2001US6218522 Nucleotide sequences associated with the inhibition of gene expression; for detecting cancer; viricides
04/17/2001US6218521 Isolated nucleic acid molecules associated with gastric cancer and methods for diagnosing and treating gastric cancer
04/17/2001US6218520 Nucleotide probe for the detection of preferential proteins; for treatment of reproductive defcets, inflammatory and autoimmune diseases
04/17/2001US6218517 Protein having a vascularization inhibitory effect and a method for production thereof and a method for producing angiostatin
04/17/2001US6218515 Cyclin E variants and use thereof
04/17/2001US6218514 Immunoglobulins preferential for a soluble cellular adhesion molecule; for the detection of tumor cells in a sample
04/17/2001US6218513 Genetically engineered hemoglobins; for used to treat anemia and hemorrhages; for amplification of cells oxygen carrying capabilities
04/17/2001US6218512 Genes determining cellular senescence in yeast
04/17/2001US6218511 Anti-apoptotic genes of human cytomegalovirus (HCMV) and their use
04/17/2001US6218510 Proteins associated with the activation of lymphocytes and monocytes; for treatment of immune defects
04/17/2001US6218509 LH/CG receptor, DNA and use thereof
04/17/2001US6218508 Anti-microbial proteins
04/17/2001US6218507 Synthetic peptides for the detection of trimethylamine (TMA) and their detection method and device
04/17/2001US6218506 Soluble brain protein for the detection, prevention and treatment of alzhiemer's disease
04/17/2001US6218372 Methods for treating restenosis with p21
04/17/2001US6218363 MHC peptides and methods of use
04/17/2001US6218362 For therapy and prophylaxis of bacterial infections
04/17/2001US6218360 Collagen based biomaterials and methods of preparation and use
04/17/2001US6218359 Treating autoimmune, arthritic, tumor diseases
04/17/2001US6218356 Neural receptor tyrosine kinase
04/17/2001US6218188 Polynucleotide sequence for expression of pesticide in eukaryotic cells; for biological pest control
04/17/2001US6218187 Infect human stem cells with microoganism supernatant; transfect cells, separate cells from supernatant, add adhesion molecules to culture plates, propagate second group of cells with supernantant and recover transduced cells
04/17/2001US6218185 Expression vectors for the insertion of heterologous gene into cells
04/17/2001US6218181 Retroviral packaging cell line
04/17/2001US6218180 Virion coding a toxic agent, cytokine and tumor suppressor; for the treatment of tumorous defects; antitumor agents
04/17/2001US6218179 Nucleotide sequences coding human metallothionein regulatory sequences; for reducing ischemic injury to a cell exposed to hypoxic conditions
04/17/2001US6218164 Thermopallium bacteria and enzymes obtainable therefrom
04/17/2001US6218149 Altering affinity of antibody for antigen by deleting dna encoding a carbohydrate recognition site from variable domain of antibody, expressing mutagenized gene, measuring affinity of altered antibody and comparing to control
04/17/2001US6218148 DNS encoding stem cell factor
04/17/2001US6218147 Haemophilus adhesin protein
04/17/2001US6218146 MTS2 gene
04/17/2001US6218145 Bacterial expression systems based on plastic or mitochondrial promoter combinations
04/17/2001US6218144 Nucleic acid encoding a cos2 protein of defined amino acid sequence involved in hedgehog signaling pathway; anticarcinogenic agents
04/17/2001US6218141 Assembling expression vector using defined nucleotide sequence coding for protein, transforming host cell, then expressing, isolating, and purifying protein
04/17/2001US6218131 Diagnosis by detecting presence of protein of defined amino acid sequence in sample
04/17/2001US6218127 Identifying patient having head/neck squamous cell carcinoma who would benefit from radiation/chemotherapy by analyzing dna for loss of heterozygosity in mannose-6-phosphate/ insulin-like growth factor receptor gene, a tumor suppressor